Abstract
We report three patients who had serious disturbance of anticoagulant control while receiving ifosfamide/mesna-containing cytotoxic chemotherapy in association with warfarin. In view of the likely biological potentiation of warfarin by ifosfamide/mesna, close monitoring of anticoagulant control should be performed during the co-administration of these drugs.
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Blood Coagulation / drug effects*
-
Blood Coagulation Disorders / prevention & control
-
Drug Interactions
-
Drug Synergism
-
Female
-
Humans
-
Ifosfamide / administration & dosage
-
Ifosfamide / adverse effects*
-
Infusions, Intravenous
-
Male
-
Mesna / administration & dosage
-
Mesna / adverse effects*
-
Middle Aged
-
Warfarin / administration & dosage
-
Warfarin / therapeutic use*
Substances
-
Warfarin
-
Mesna
-
Ifosfamide